These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. Suh JM, Song JH, Kim DW, Kim H, Chung HK, Hwang JH, Kim JM, Hwang ES, Chung J, Han JH, Cho BY, Ro HK, Shong M. J Biol Chem; 2003 Jun 13; 278(24):21960-71. PubMed ID: 12668683 [Abstract] [Full Text] [Related]
4. Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells. Liu YY, Zhang X, Ringel MD, Jhiang SM. Endocr Relat Cancer; 2012 Jun 13; 19(3):291-304. PubMed ID: 22355179 [Abstract] [Full Text] [Related]
7. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Gulati N, Karsy M, Albert L, Murali R, Jhanwar-Uniyal M. Int J Oncol; 2009 Oct 13; 35(4):731-40. PubMed ID: 19724909 [Abstract] [Full Text] [Related]
9. Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways. Hou P, Bojdani E, Xing M. J Clin Endocrinol Metab; 2010 Feb 13; 95(2):820-8. PubMed ID: 20008023 [Abstract] [Full Text] [Related]
10. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Lee KW, Yook JY, Son MY, Kim MJ, Koo DB, Han YM, Cho YS. Stem Cells Dev; 2010 Apr 13; 19(4):557-68. PubMed ID: 19642865 [Abstract] [Full Text] [Related]
12. cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4. Blancquaert S, Wang L, Paternot S, Coulonval K, Dumont JE, Harris TE, Roger PP. Mol Endocrinol; 2010 Jul 13; 24(7):1453-68. PubMed ID: 20484410 [Abstract] [Full Text] [Related]
14. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, Fu H, Khuri FR. Cancer Res; 2005 Aug 15; 65(16):7052-8. PubMed ID: 16103051 [Abstract] [Full Text] [Related]
15. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F. Invest Ophthalmol Vis Sci; 2010 Jan 15; 51(1):421-9. PubMed ID: 19661225 [Abstract] [Full Text] [Related]
16. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB. Varma S, Khandelwal RL. Biochim Biophys Acta; 2007 Jan 15; 1770(1):71-8. PubMed ID: 16952420 [Abstract] [Full Text] [Related]
20. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI. Endocr Relat Cancer; 2005 Mar 15; 12(1):119-34. PubMed ID: 15788644 [Abstract] [Full Text] [Related] Page: [Next] [New Search]